{
  "trial_id": "NCT02688803",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically confirmed primary TNBC breast cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Planned for chemotherapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "\u226518 years of age",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Able to provide verbal consent",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Willing to complete a survey",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Metastatic disease",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Contraindication to one or more of the chemotherapy agents being evaluated in the study",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT02688803",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}